Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 5C7H11N2O4.3Al.4HO |
Molecular Weight | 1084.8402 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Al+3].CC(=O)N[C@@H](CCC(N)=O)C([O-])=O.CC(=O)N[C@@H](CCC(N)=O)C([O-])=O.CC(=O)N[C@@H](CCC(N)=O)C([O-])=O.CC(=O)N[C@@H](CCC(N)=O)C([O-])=O.CC(=O)N[C@@H](CCC(N)=O)C([O-])=O
InChI
InChIKey=IVVHAAOJLULJLK-YDXSIYMFSA-E
InChI=1S/5C7H12N2O4.3Al.4H2O/c5*1-4(10)9-5(7(12)13)2-3-6(8)11;;;;;;;/h5*5H,2-3H2,1H3,(H2,8,11)(H,9,10)(H,12,13);;;;4*1H2/q;;;;;3*+3;;;;/p-9/t5*5-;;;;;;;/m00000......./s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3814209Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/aceglutamide.html | https://www.ncbi.nlm.nih.gov/pubmed/26444640 | https://www.ncbi.nlm.nih.gov/pubmed/1790087 | https://www.ncbi.nlm.nih.gov/pubmed/7274416
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3814209
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/aceglutamide.html | https://www.ncbi.nlm.nih.gov/pubmed/26444640 | https://www.ncbi.nlm.nih.gov/pubmed/1790087 | https://www.ncbi.nlm.nih.gov/pubmed/7274416
Aceglutamide (INN, JAN) (brand name Neuramina), or aceglutamide aluminum (JAN, USAN) (brand name Glumal), also known as acetylglutamine, is a psychostimulant, nootropic, and antiulcer agent that is marketed in Spain and Japan. Aceglutamide functions as a prodrug to glutamine with improved potency and stability. Aceglutamide is used as a psychostimulant and nootropic, while aceglutamide aluminum is used in the treatment of ulcers. Aceglutamide can also be used as a liquid-stable source of glutamine to prevent damage from protein energy malnutrition.
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
N-acetyl functions and acetate detected by nuclear magnetic resonance spectroscopy of urine to detect renal dysfunction following aminoglycoside and/or glycopeptide antibiotic therapy. | 2004 |
|
Absorption of enterally administered N-acetyl-l-glutamine versus glutamine in pigs. | 2004 Dec |
|
N-acetyl-L-glutamine, a liquid-stable source of glutamine, partially prevents changes in body weight and on intestinal immunity induced by protein energy malnutrition in pigs. | 2007 Mar |
|
Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis. | 2010 Jul |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1790087
700 mg bid
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28202289
Rat pheochromocytoma cell lines (PC12) were cultured in RPMI-1640 supplemented with 5% FBS and 10% HS, at 37◦C in a humidified atmosphere of 5% CO2 and 95% oxygen. The cells were incubated with Na2S2O4 at a final concentration of 10mM in the sugar and glutamine-free Earle’s solution for 4 h (hypoxia) and the cell solution was then replaced by normal medium without adding glutamine (reoxygenation). Series concentrations of Aceglutamide (0.01, 0.1, 1 and 10 mkM) were added into the culture medium 24 h after the onset of reoxygenation. Control cultures were treated in a similar way except the hypoxic challenge.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29701
Created by
admin on Fri Dec 15 15:13:36 GMT 2023 , Edited by admin on Fri Dec 15 15:13:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
U-100
Created by
admin on Fri Dec 15 15:13:36 GMT 2023 , Edited by admin on Fri Dec 15 15:13:36 GMT 2023
|
PRIMARY | |||
|
DTXSID90925394
Created by
admin on Fri Dec 15 15:13:36 GMT 2023 , Edited by admin on Fri Dec 15 15:13:36 GMT 2023
|
PRIMARY | |||
|
SUB00244MIG
Created by
admin on Fri Dec 15 15:13:36 GMT 2023 , Edited by admin on Fri Dec 15 15:13:36 GMT 2023
|
PRIMARY | |||
|
m1296
Created by
admin on Fri Dec 15 15:13:36 GMT 2023 , Edited by admin on Fri Dec 15 15:13:36 GMT 2023
|
PRIMARY | Merck Index | ||
|
1426378
Created by
admin on Fri Dec 15 15:13:36 GMT 2023 , Edited by admin on Fri Dec 15 15:13:36 GMT 2023
|
PRIMARY | RxNorm | ||
|
10463869
Created by
admin on Fri Dec 15 15:13:36 GMT 2023 , Edited by admin on Fri Dec 15 15:13:36 GMT 2023
|
PRIMARY | |||
|
12607-92-0
Created by
admin on Fri Dec 15 15:13:36 GMT 2023 , Edited by admin on Fri Dec 15 15:13:36 GMT 2023
|
PRIMARY | |||
|
C81602
Created by
admin on Fri Dec 15 15:13:36 GMT 2023 , Edited by admin on Fri Dec 15 15:13:36 GMT 2023
|
PRIMARY | |||
|
R7QTG0PMPX
Created by
admin on Fri Dec 15 15:13:36 GMT 2023 , Edited by admin on Fri Dec 15 15:13:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD